Table 3.
Tumor Types | Expression | Diagnostic or Prognostic Value | Ref. |
---|---|---|---|
Bladder cancer | Up | Poor OS, and poor PFS, AUC > 0.8 | [24] |
Up | Poor OS | [21] | |
Cervical cancer | Up | Shorter OS and DFS | [28] |
Colorectal cancer | Up | Worse OS | [30] |
Up | Poor OS | [31] | |
Gastric cancer | Up | Worse prognosis | [34] |
Hepatocellular carcinoma | Up | Poor OS | [36] |
Up | Poor OS and DFS | [37] | |
Up | Shorter OS | [38] | |
Up | Poor PFS | [132] | |
Lung cancer | Up | Tissue PCAT6: AUC > 0.9, sensitivity 86.67–100%, specificity 78.57–96%Plasma PCAT6: a. LUAD: AUC = 0.9213, sensitivity 87.67%, specificity 97.44; b. LUSC: AUC = 0.9583, sensitivity 94.12%, specificity 100% | [41] |
Up | Poor OS | [40] | |
Up | Poor OS | [20] | |
Up | Poor OS | [43] | |
Osteosarcoma | Up | Shorter OS and PFS | [44] |
Up | Shorter OS and PFS | [45] | |
Ovarian cancer | Up | Poor OS, PFS and PPS | [48] |
Pancreatic ductal adenocarcinoma | Up | Worse OS | [51] |
Prostate cancer | Up | Shorter overall and BM-free survival, shorter DFS | [53] |
OS, overall survival; PFS, progression-free survival; AUC, area under curve; DFS, disease-free survival; PPS, post progression survival.